David Bakish
About
In The Last Decade
David Bakish
71 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cellular and Molecular Neuroscience 1.1k
- Psychiatry and Mental health 932
- Pharmacology 920
- Clinical Psychology 643
- Molecular Biology 626
Countries citing papers authored by David Bakish
This map shows the geographic impact of David Bakish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bakish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bakish more than expected).
Fields of papers citing papers by David Bakish
This network shows the impact of papers produced by David Bakish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bakish. The network helps show where David Bakish may publish in the future.
Co-authorship network of co-authors of David Bakish
This figure shows the co-authorship network connecting the top 25 collaborators of David Bakish. A scholar is included among the top collaborators of David Bakish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bakish. David Bakish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 150 | |
| 3 | 26 | |
| 4 | 80 | |
| 5 | New standard of depression treatment: remission and full recovery. | 99 |
| 6 | 48 | |
| 7 | 142 | |
| 8 | 51 | |
| 9 | 9 | |
| 10 | Serotonin in the Central Nervous System and Periphery. | 51 |
| 11 | A comparison of placebo response with major depressive disorder in patients recruited through newspaper advertising versus consultation referrals. | 13 |
| 12 | 91 | |
| 13 | 3 | |
| 14 | 49 | |
| 15 | 5-HT1A Agonists, 5-HT3 Antagonists and Benzodiazepines: Their Comparative Behavioral Pharmacology. | 29 |
| 16 | 3 | |
| 17 | GABAergic Synaptic Transmission: Molecular, Pharmacological, and Clinical Aspects | 15 |
| 18 | 3 | |
| 19 | 12 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.